Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flublok vs Standard Flu Vaccine in Nursing Homes
NCT03965195Phase 4Unknown
- Sponsor
- Insight Therapeutics
- Start
- Jul 2019
- Primary completion
- Aug 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of influenza vaccine in influenza (2 arms), sponsored by Insight Therapeutics. Primary endpoint: Differences in all-cause hospitalization rates. Status: unknown.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03965195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03965195.